AI in Medicine Nanoparticle Technology Patient Wellbeing New Treatments Biomarkers Evidence-Based Medicine NIH Funding Exercise Benefits Patient Outcomes
Johns Hopkins researchers validate non-invasive, early-response blood test in phase 2 trials, paving the way for improved patient outcomes and broader cancer applications.